The recent run of first-quarter…
The recent run of first-quarter earnings results marked a shift [...]
Ipsen has set aside the two drug…
Ipsen has set aside the two drug candidates it picked [...]
The company announced it has…
The company announced it has concluded development of the plasma [...]
GSK has found another potential…
GSK has found another potential way to treat cardiometabolic disease [...]
With Gilead’s $7.8 billion buyout…
With Gilead’s $7.8 billion buyout of Arcellx complete, the California [...]
Madrigal Pharmaceuticals has…
Madrigal Pharmaceuticals has struck a backloaded deal for the global [...]
Pfizer’s $2.3 billion bet on…
Pfizer’s $2.3 billion bet on Trillium Therapeutics doesn’t look like [...]
After pausing a trial for a…
After pausing a trial for a Moderna-partnered cystic fibrosis candidate [...]
After some tough feedback from the…
After some tough feedback from the FDA on the path [...]
Mirum Pharmaceuticals is moving…
Mirum Pharmaceuticals is moving toward an FDA filing after its [...]